Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 421.77 million as of May 13, 2025. Its market cap has increased by 35.36% in one year.

Market Cap

421.77M

Enterprise Value

384.94M

Revenue

31.65M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.96

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 421.77M, a decrease of -74.74%. That is a compound annual growth rate of -15.41%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	401.54M	19.92%
Dec 30, 2024	334.83M	-53.79%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	11.53B	63.96%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	102.97B
Sectra AB	59.23B
Getinge AB	50.70B
Camurus AB	39.14B
Medicover AB	36.18B
AddLife AB	22.95B
Vitrolife AB	21.42B
Vimian Group AB	20.64B

Market Cap Rankings